These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 25298402)

  • 1. Formation of α-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes.
    Volpicelli-Daley LA; Gamble KL; Schultheiss CE; Riddle DM; West AB; Lee VM
    Mol Biol Cell; 2014 Dec; 25(25):4010-23. PubMed ID: 25298402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
    De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.
    Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
    Volpicelli-Daley LA; Luk KC; Patel TP; Tanik SA; Riddle DM; Stieber A; Meaney DF; Trojanowski JQ; Lee VM
    Neuron; 2011 Oct; 72(1):57-71. PubMed ID: 21982369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assays for Neuronal Defects Caused by Early Formation of α-Synuclein Inclusions in Primary Cultured Neurons.
    Volpicelli-Daley LA
    Methods Mol Biol; 2019; 1948():1-14. PubMed ID: 30771165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.
    Volpicelli-Daley LA; Luk KC; Lee VM
    Nat Protoc; 2014 Sep; 9(9):2135-46. PubMed ID: 25122523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
    Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
    J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae.
    Soper JH; Roy S; Stieber A; Lee E; Wilson RB; Trojanowski JQ; Burd CG; Lee VM
    Mol Biol Cell; 2008 Mar; 19(3):1093-103. PubMed ID: 18172022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro.
    Marotta NP; Ara J; Uemura N; Lougee MG; Meymand ES; Zhang B; Petersson EJ; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2021 Nov; 9(1):188. PubMed ID: 34819159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of α-synuclein on axonal transport.
    Volpicelli-Daley LA
    Neurobiol Dis; 2017 Sep; 105():321-327. PubMed ID: 27956085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models of α-synuclein transport in axons.
    Kuznetsov IA; Kuznetsov AV
    Comput Methods Biomech Biomed Engin; 2016; 19(5):515-26. PubMed ID: 26207359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
    Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.
    Peña-Díaz S; Pujols J; Vasili E; Pinheiro F; Santos J; Manglano-Artuñedo Z; Outeiro TF; Ventura S
    J Biol Chem; 2022 May; 298(5):101902. PubMed ID: 35390347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
    Peng C; Gathagan RJ; Covell DJ; Medellin C; Stieber A; Robinson JL; Zhang B; Pitkin RM; Olufemi MF; Luk KC; Trojanowski JQ; Lee VM
    Nature; 2018 May; 557(7706):558-563. PubMed ID: 29743672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.
    Karpowicz RJ; Haney CM; Mihaila TS; Sandler RM; Petersson EJ; Lee VM
    J Biol Chem; 2017 Aug; 292(32):13482-13497. PubMed ID: 28611062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.
    Prots I; Grosch J; Brazdis RM; Simmnacher K; Veber V; Havlicek S; Hannappel C; Krach F; Krumbiegel M; Schütz O; Reis A; Wrasidlo W; Galasko DR; Groemer TW; Masliah E; Schlötzer-Schrehardt U; Xiang W; Winkler J; Winner B
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7813-7818. PubMed ID: 29991596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.